2013 MedTech retrospective

For the MedTech industry there was a mixed bag of results, innovation and regulatory changes.  Venture capital has not returned to pre-2008 levels in most medical technology sectors, the medical device tax in the United States was widely debated by industry, US Congress and the news media.  I found the following reports helpful in understanding this mixed bag.

AdvaMed summary of cuts and taxes impacting medical industry (Aug 2013)

PWC – Q3 2013 report illustrates the funding landscape, top metropolitan areas for investing in biotech/medtech.

Author: John S. Bolinder |

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s